I agree that this site is using cookies. You can find further informations here.
X
Gaudreau, Pierre-Olivier
156  results:
Search for persons X
?
1

Brief Report: Real-World Eligibility for Clinical Trials in..:

Dehar, Navdeep ; Meem, Mahbuba ; Aggarwal, Ishita...
JTO Clinical and Research Reports.  5 (2024)  7 - p. 100696 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Brief Report: Canadian Cancer Trials Group IND.227: A Phase..:

Piccirillo, Maria Carmela ; Chu, Quincy ; Bradbury, Penelope...
Journal of Thoracic Oncology.  18 (2023)  6 - p. 813-819 , 2023
Link: https://doi.org/10.1016/..
 
?
3

A study of the efficacy and toxicity outcomes of extended d..:

Hanna, Lilian ; Moffat, Gordon Taylor ; Hopman, Wilma..
Cancer Treatment and Research Communications.  34 (2023)  - p. 100678 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Prospective Evaluation of Fetal Hemoglobin Expression in Ma..:

Blain, Laurence ; Watier, Christian ; Weng, Xiaoduan...
Diagnostics.  13 (2023)  11 - p. 1873 , 2023
Link: https://doi.org/10.3390/..
 
?
5

iRECIST and atypical patterns of response to immuno-oncolog..:

Ramon-Patino, Jorge Luis ; Schmid, Sabine ; Lau, Sally...
Journal for ImmunoTherapy of Cancer.  10 (2022)  6 - p. e004849 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Dietary fiber and probiotics influence the gut microbiome a..:

Spencer, Christine N. ; McQuade, Jennifer L. ; Gopalakrishnan, Vancheswaran...
Science.  374 (2021)  6575 - p. 1632-1640 , 2021
Link: https://doi.org/10.1126/..
 
?
7

Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue..:

Gaudreau, Pierre-Olivier ; Negrao, Marcelo V. ; Mitchell, Kyle G....
Journal of Thoracic Oncology.  16 (2021)  1 - p. 127-139 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Th17 cells contribute to combination MEK inhibitor and anti..:

Peng, David H. ; Rodriguez, B. Leticia ; Diao, Lixia...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

A phase I/II study of pembrolizumab in combination with nab..:

Nassabein, Rami ; Gaudreau, Pierre-Olivier ; Belkaid, Wiam..
Cancer Treatment and Research Communications.  28 (2021)  - p. 100421 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Phase I/II Trial of Immunotherapy With Durvalumab and Treme..:

Gaudreau, Pierre-Olivier ; Lee, J. Jack ; Heymach, John V..
Clinical Lung Cancer.  21 (2020)  4 - p. 384-388 , 2020
Link: https://doi.org/10.1016/..
 
?
11

B cells and tertiary lymphoid structures promote immunother..:

Helmink, Beth A. ; Reddy, Sangeetha M. ; Gao, Jianjun...
Nature.  577 (2020)  7791 - p. 549-555 , 2020
Link: https://doi.org/10.1038/..
 
?
12

Sustained Type I interferon signaling as a mechanism of res..:

Jacquelot, Nicolas ; Yamazaki, Takahiro ; Roberti, Maria P....
Cell Research.  29 (2019)  10 - p. 846-861 , 2019
Link: https://doi.org/10.1038/..
 
?
13

Immune Checkpoint Blockade across the Cancer Care Continuum:

Helmink, Beth A. ; Gaudreau, Pierre-Olivier ; Wargo, Jennifer A.
Immunity.  48 (2018)  6 - p. 1077-1080 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Immunotherapy Comes of Age in Lung Cancer:

Khanna, Priyanka ; Blais, Normand ; Gaudreau, Pierre-Olivier.
Clinical Lung Cancer.  18 (2017)  1 - p. 13-22 , 2017
Link: https://doi.org/10.1016/..
 
?
15

The Present and Future of Biomarkers in Prostate Cancer: Pr..:

Gaudreau, Pierre-Olivier ; Stagg, John ; Soulières, Denis.
Biomarkers in Cancer.  8s2 (2016)  - p. BIC.S31802 , 2016
Link: https://doi.org/10.4137/..
 
1-15